Role of APOE in dementia: A critical reappraisal

Haemostasis

Volumn 28, Issue 3-4, 1998, Pages 195-201

  De Knijff, Peter ^a   Van Duijn, Cornelia M ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dementia

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ARTICLE; DNA POLYMORPHISM; GENOTYPE; HUMAN; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0032462432     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022430     Document Type: Article

References (26)

1. Yanker BA, Mesulam M-M: β-Amyloid and the pathogenesis of Alzheimer's disease. N Engl J Med 1991;325:1849-1857.
2. Breteler MMB, Claus JJ, van Duijn CM, Launer LJ, Hofman A: Epidemiology of Alzheimer's Disease. Epidemiol Rev 1992;14:59-82.
3. Skoog I, Nilson L, Palmertz B, Andreasson L-A, Svanborg A: A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328:153-158.
4. Lendon C, Ashall F, Goate AM: Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 1997;277:825-831.
5. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD: Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
6. Corder EH, Saunders AM, Strittmatter WJ, Schmechel D, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA: Gene dose of apoliprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
7. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-Maclachlan DR, Alberts MJ, Hulette C, Grain B, Goldgaber D, Roses AD: Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
8. van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, van Broeckhoven C: Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 1994;7:74-78.
9. Feskens EJM, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D: Apolipoprotein E4 allele and cognitive decline in elderly man. BMJ 1994;309:1202-1206.
10. Fairer LA, Cupples A, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericek-Vance MA, Risch N, van Duijn CM, for the APOE and Alzheimer's Disease Meta-Analysis Consortium: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: A meta-analysis. JAMA 1997;278:1349-1356.
11. Strittmatter WJ, Weisgraber KH, Huang DY, Dong L-M, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD: Binding of human apolipoprotein E to synthetic amyloid β-peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:8089-8102.
12. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE: Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 1994;269:23404-23406.
13. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong L-M, Jakes R, Alberts MJ, Gilbert JR, Han S-H, Hulette C, Einstein G, Schmechel DE, Pericak-Vance MA, Roses AD: Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E geno-type. Exp Neurol 1994;125:163-171.
14. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE: Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994;264:850-852.
15. Miyate M, Smith J: Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and p-amyloid peptides. Nat Genet 1996;14:55-61.
16. LaDu MJ, Pederson TM, Frail DE, Reardon CA, Getz GS, Falduto MT: Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J Biol Chem 1995;270:9039-9042.
17. Slooter AJC, Tang M-X, van Duijn CM, Stern Y, Ott A, Bell K, Breteler MMB, van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R: Apolipoprotein E ε4 and the risk of dementia with stroke. JAMA 1997;277:818-821.
18. de Knijff P, van den Maagdenberg AMJM, Frants RR, Havekes LM: Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutat 1994;4:178-194.
19. Smit M, van de Kooij-Meijs E, Woudt LP, Havekes LM, Frants RR: Exact localization of the familial dysbetalipoproteinemia associated HpaI restriction site in the promotor region of the APOC1 gene. Biochem Biophys Res Commun 1988;152:1282-1288.
20. de Knijff P, van den Maagdenberg AMJM, Stalenhoef AFH, Gevers Leuven JA, Demacker PNM, Kuyt LP, Frants RR, Havekes LM: Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree. J Clin Invest 1991;88:643-655.
21. van den Maagdenberg AMJM, Weng W, de Bruijn IH, de Knijff P, Funke H, Smelt AHM, Gevers Leuven JA, van't Hooft FM, Assmann G, Hofker MH, Havekes LM, Frants RR: Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: No coseggragation with severe hyperlipidemia. Am J Hum Genet 1993;52:937-946.
22. de Knijff P, van den Maagdenberg AMJM, Boomsma DI, Stalenhoef AFH, Smelt AHM, Kastelein J, Marais AD, Frants RR, Havekes LM: Variable expression of familial dysbetalipoproteinemia (FD) associated with apolipoprotein E2(Lys1 46→ Gln). J Clin Invest 1994;94:1252-1262.
23. Mui S, Briggs M, Chung H, Wallace RB, Gomez-Isla T, Rebeck GW, Hyman BT: A newly identified polymorphism in the apolipoprotein E gene enhancer region is associated with AD and strongly with the c4 allele. Neurology 1996;47:196-201.
24. Lambert J-C, Pasquir F, Cottel D, Frigard B, Maouyel P, Chartier-Harlin M-C: A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet 1998;7:533-540.
25. Bales KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM: Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat Genet 1997;17:263-264.
26. van Duijn CM, de Knijff P, Wehnert A, De Voecht J, Bronzova JB, Havekes LM, Hofman A, Van Broeckhoven C: Reduced survival of patients with early-onset Alzheimer's disease that carry the apolipoprotein E2 allele. Ann Neurology 1995;37:605-610.